Type 1 diabetes: Semaglutide is being investigated as a potential adjunct therapy for type 1 diabetes
You may feel more tempted to snack, especially on high-calorie foods
and (v) adverse event reportingspecifically, that as of May 21, 2026, FDA had received more than 1,700 adverse events associated with compounded semaglutide and tirzepatide
Understanding the Ketogenic Diet: Principles and Effects The ketogenic (keto) diet is a high-fat, moderate-protein, and very low-carbohydrate eating pattern that fundamentally alters the body's primary fuel source
Confidential environment: Procedures are conducted privately to ensure comfort and discretion
Oral GLP-1 weight loss medication Orfoglipron (Eli Lilly) is nearing an FDA decision with available expect mid-2026 Clinical trials show meaningful results: 12-16% 1,2 average weight loss, which is slightly less than injectables Side effects are similar: mostly gastrointestinal, such as nausea or diarrhea, typically improving over 23 months